UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325
Home » Archive of numbers » 2024 » Volume 32, issue 3 (120) » EFFECTIVENESS OF LIDOCAINE BLOCKADES IN PATIENTS WITH SEVERE FORMS OF TRIGEMINAL NEURALGIA

EFFECTIVENESS OF LIDOCAINE BLOCKADES IN PATIENTS WITH SEVERE FORMS OF TRIGEMINAL NEURALGIA

Authors

Type of Article

  • Scientific Article

In the Section

  • MECHANISMS OF FORMATION AND MODERN PRINCIPLES OF TREATMENT OF NEUROLOGICAL DISORDERS

Key words

Index UDK:
  • 616.833.15-009.7-089

Abstract

  • The purpose of the present work was to study the effectiveness of lidocaine blockades (LB) in patients with severe forms of the trigeminal neuralgia (TN) in the close and long-term perspective. We analyzed the results of treatment of 45 patients (15 men and 30 women) with severe forms of TN using peripheral branch blockadess with 2 % lidocaine solution, which were performed according to the commonly accepted method. The age of patients ranged from 34 to 88 years (mean ± SD — 63,69 ± 12,31). All patients were referred to a neurosurgical clinic due to the ineffectiveness of previous drug therapy. The effectiveness was estimated at different periods after applied blockades using visual and analog rating scales at different times: at hospitalization (before the blockade started), in 30 minutes, in six hours, in one day (24 hours), in three days, in one month, in three months, in six months, in one year, in two years, and in three years after the blockades. LB of peripheral branches of trigeminal nerve in patients with severe pharmacoresistant forms of TN appeared to be effective in 100.00 % of patients in the first 3—6 hours after the implementation. Subsequently, the analgesic effect of NB is decreasing, especially in the coming weeks, that necessitated the use of more radical methods of neurosurgical treatment. Excellent long-term (after 2—3 years) results after the use of blockades on the background of adequately selected pathogenetic therapy of both the main and concomitant diseases of the nervous system and internal organs were achieved in 4 (8.89 %) of 45 patients. Thus, we can conclude that in case of ineffectiveness of conservative drug therapy, using of LB of the peripheral branches of trigeminal nerve is advisable within the complex treatment of patients with TN.

Pages

  • 4-13

Year / Issue

Download PDF

Bibliography

1. Headache Classification Committee of the International Headache Society (IHS) The  International Classification of Headache Disorders, 3rd edition // Cephalalgia. 2018.Vol. 38 (1). P. 1—211. DOI: 10.1177/0333102417738202.
2. European Academy of Neurology guideline on trigeminalneuralgia / Bendtsen L., Zakrzewska J. M., Abbott J. [et al.] //Eur J Neurol. 2019. Vol. 26(6). P. 831—849. DOI: 10.1111/ene.13950.
3. Cruccu G. Trigeminal Neuralgia / G. Cruccu, G. Di Stefanoand A. Truini // N Engl J Med. 2020. Vol. 383. P. 754—62. DOI:10.1056/NEJMra1914484.
4. The Effect of Intravenous Lidocaine on Trigeminal Neuralgia: A Randomized Double Blind Placebo Controlled Trial /Stavropoulou  E., Argyra E., Zis  P. [et al.] // ISRN Pain. 2014.10;2014:853826. DOI: 10.1155/2014/853826.
5. Clinical Outcome of Percutaneous Trigeminal Nerve Blockin Elderly Patients in Outpatient Clinics / Seo H. J., Park C. K.,Choi M. K. [et al.] // J Korean Neurosurg Soc. 2020. Vol. 63 (6).P. 814—820. DOI: 10.3340/jkns.2020.0139.
6. Comparing the clinical features of lateral and  medialapproaches of costoclavicular technique versus traditionallateral sagittal technique as infraclavicular brachial plexusblock methods: a randomized controlled trial / Bingül E. S.,Canbaz M., Güzel M. [et al.] // BMC Anesthesiol. 2024. Vol. 24 (1).P. 254. DOI: 10.1186/s12871-024-02645-z.
7. Intravenous Lidocaine for the Management of Chronic Pain: A Narrative Review of Randomized Clinical Trials /Onyeaka H., Adeola J., Xu R. [et al.] // Psychopharmacol Bull.2024. Vol. 54 (3). P. 73—96. PMID: 38993659.
8. Greenberg, M. S. Handbook of Neurosurgery. New York:Thieme Medical Publishers, 2006. 1000 p. URI: https://archive.org/details/handbookofneuros0006gree.
9. Xu, R. Trigeminal Neuralgia: Current Approaches and Emerging Interventions / R. Xu, M. E. Xie, C. M. Jackson // Journalof Pain Research. 2021. Vol. 14. P. 3437—3463. DOI: 10.2147/JPR.S331036.
10. Combination of pharmacotherapy and lidocaine analgesic block of the peripheral trigeminal branches for trigeminalneuralgia: a  pilot study / F. Di  Stani, C. Ojango, D.  Dugoni [et al.] // Arquivos de Neuro-Psiquiatria. 2015. Vol. 73, No. 8.P. 660—664. DOI: 10.1590/0004-282X20150077.
11. Trigeminal neuralgia: New classification and diagnosticgrading for practice and research / G. Cruccu, N. B. Finnerup,T. S. Jensen [et al.] // Neurology. 2016. Vol. 87, No. 2. P. 220—228. DOI: 10.1212/WNL.0000000000002840.
12. Nerve block for the treatment of headaches and cranial neuralgias – a practical approach / [Dach F., Éckeli Á. L.,Ferreira Kdos  S., Speciali  J.  G.]  // Headache. 2015. Vol.  55,Suppl 1. P. 59—71. DOI: 10.1111/head.12516.
13. Non-Surgical Treatments of Trigeminal Neuralgia from thePerspective of a Pain Physician: A Narrative Review / J. Y. Lee,G. H. Lee, S. H. Yi [et al.] // Biomedicines. 2023. Vol. 11 (8),No. 2315. DOI: 10.3390/biomedicines11082315.
14. Posokhov M. F. Modern problems in neurosurgical treatment of pharmacoresistant facial pains // Український вісникпсихоневрології. 2016. Т. 24, вип. 1 (86). С. 101—103.
15. Age  as  a  Factor in  the Efficacy of  Lidocaine Blockades for Trigeminal Neuralgia / C. D. Johnson, S. H. Yi, B. Kim[et al.] // Pain Medicine. 2018. Vol. 19, No. 5. P. 1007—1013.
16. Williamson, A. Pain: a  review of  three commonlyused pain rating scales / A. Williamson, B. Hoggart  // Journal of Clinical Nursing. 2005. Vol. 14, No. 7. P. 798—804. DOI:10.1111/j.1365-2702.2005.01121.x.
17. Bahreini, M. A comparison of three self-report pain scalesin adults with acute pain / M. Bahreini, M. Jalili, M. MoradiLakeh // Journal of Emergency Medicine. 2015. Vol. 48, No. 1.P. 10–—18. DOI: 10.1016/j.jemermed.2014.07.039.
18. Use of the visual analogue scale for health state valuation:a scoping review / M. Åström, Z. M. Thet Lwin, F. S. Teni [et al.] //Quality of Life Research. 2023. Vol. 32, No. 10. P. 2719—2729. DOI: 10.1007/s11136-023-03411-3.
19. Lack of  interchangeability between visual analogueand  verbal rating pain scales: a  cross-sectional descriptionof pain etiology groups / I. Lund, T. Lundeberg, L. Sandberg[et al.] // BMC Medical Research Methodology. 2005. Vol. 5.P. 31. DOI: 10.1186/1471-2288-5-31.
20. Measures of adult pain: Visual Analog Scale for Pain (VASPain), Numeric Rating Scale for Pain (NRS Pain), McGill PainQuestionnaire (MPQ), Short-Form McGill Pain Questionnaire(SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36Bodily Pain Scale (SF-36 BPS), and  Measure of  Intermittentand Constant Osteoarthritis Pain (ICOAP) / Hawker G. A., Mian S.,Kendzerska T., French M. // Arthritis Care Research (Hoboken).2011. Vol. 63, Suppl. 11. P. S240—S252. DOI: 10.1002/acr.20543.
21. Epidemiology of  trigeminal neuralgia: an  electronicpopulation health data study in Korea / C. H. Lee, H. Y. Jang,H. S. Won [et al.] // Korean Journal of Pain. 2021. Vol. 34, No. 3.P. 332—338. DOI: 10.3344/kjp.2021.34.3.332.
22. Al-Quliti, K. W. Update on neuropathic pain treatmentfor trigeminal neuralgia: The pharmacological and surgical options // Neurosciences (Riyadh). 2015. Vol. 20, No. 2. P. 107—114. DOI: 10.17712/nsj.2015.2.20140501.
23. Ruscheweyh, R. Trigeminusneuralgie: Moderne Diagnostik und Therapie / R. Ruscheweyh, J. Lutz, J. H. Mehrkens //Schmerz. 2020. Vol. 34, No. 6. P. 486—494. DOI: 10.1007/s00482-020-00496-4.
24. The PATCH trial: efficacy and safety of 5 % lidocainemedicated plaster for the treatment of patients with trigeminalneuralgia / C. Zhao, N. Shrestha, H. Liu [et al.] // BMJ Open. 2021.Vol. 11, No. 8. e045493. DOI: 10.1136/bmjopen-2020-045493.
25. Jafree, D. J. Impact of pain and postoperative complications on patient-reported outcome measures 5 years after microvascular decompression or partial sensory rhizotomyfor trigeminal neuralgia / D. J. Jafree, A. C. Williams, J. M. Zakrzewska // Acta Neurochirurgica (Wien). 2018. Vol. 160, No. 1.P. 125—134. DOI: 10.1007/s00701-017-3350-6.
26. Balta, S. Clinical effectiveness of peripheral nerve blockswith lidocaine and corticosteroid in patients with trigeminalneuralgia / S. Balta, G. Köknel Talu // Agri. 2021. Vol. 33, No. 4.P. 237—242. DOI: 10.14744/agri.2021.26032.
27. Comparative study of effect of single and multiple nerveblocks on treatment of trigeminal neuralgia / C. H. Lee [et al.] //Journal of the Korean Association of Oral and MaxillofacialSurgeons. 2020. Vol. 46, No. 1. P. 29—36.
28. Ertilav, E. Evaluation of the effectiveness duration of peripheral blocks applied with high concentration local anestheticand steroid in trigeminal neuralgia / E. Ertilav, O. N. Aydın // Agri.2022. Vol. 34, No. 4. P. 264—271. DOI: 10.14744/agri.2021.77854.
29. Early Blockade of EphA4 Pathway Reduces TrigeminalNeuropathic Pain / [M. J. Kim, J. Y. Son, J. S. Ju, D. K. Ahn] //Journal of Pain Research. 2020. Vol. 13. P. 1173—1183. DOI: 10.2147/JPR.S249185.
30. Efficacy and safety of high concentration lidocaine fortrigeminal nerve block in patients with trigeminal neuralgia /[K. R. Han, C. Kim, Y. J. Chae, D. W. Kim] // International Journal of Clinical Practice. 2008. Vol. 62, No. 2. P. 248—254. DOI: 10.1111/j.1742-1241.2007.01568.x.
31. Фишер, Ю. Локальное лечение боли. Москва : МЕДпресс-информ, 2006. 159 с.

Journal’s Indexing:

UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine

ДУ «ІНПН імені
П.В. ВОЛОШИНА
НАМН УКРАЇНИ»